Barry L. Zaret

Thrombolysis inMyocardial Infarction (TIMI) Trial, Phase I:acomparison between intravenous tissue plasminogen activator andintravenous streptokinase*

J. H. Chesebro, Genell L. Knatterud, Robert Roberts et al. · 1987 · 735 citations

Thrombosis, Percutaneous Coronary Intervention, Cardiovascular Disease +14

Serial Assessment of Doxorubicin Cardiotoxicity with Quantitative Radionuclide Angiocardiography

J. Steven Alexander, Nicholas Dainiak, Harvey J. Berger et al. · New England Journal of Medicine · 1979 · 525 citations

Heart Failure, Pharmacotherapy, Cardiovascular Toxicity +17

Intact systolic left ventricular function in clinical congestive heart failure

Robert Soufer, Daniel Wohlgelernter, Néstor A. Vita et al. · The American Journal of Cardiology · 1985 · 522 citations

Heart Failure, Structural Heart Disease, Cardiovascular Disease +10

Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy

Ronald G. Schwartz, W. Mckenzie, J. Steven Alexander et al. · The American Journal of Medicine · 1987 · 511 citations

Cardiomyopathy, Heart Failure, Structural Heart Disease +7

A scintiphotographic method for measuring left ventricular ejection fraction in man without cardiac catheterization

H. William Strausś, Barry L. Zaret, Peter Hurley et al. · The American Journal of Cardiology · 1971 · 405 citations

Scintiphotographic Method, Cardiac Catheterization, Heart Failure +11